Lede: DOE's Office of Environmental Management is Washington's quietest big-money program: no ribbon cuttings, just $8-plus billion a year to entomb Cold War nuclear waste at Hanford, Savannah River, Idaho and a half-dozen other legacy sites. The FY2027 budget request trims total EM funding roughly 5%, to about $8.2 billion, but that's not the real signal — the mix inside DOE nuclear spending is shifting toward finishing existing cleanup obligations (which are legally mandated under consent decrees) and away from headline-grabbing new reactor construction. That reshuffle doesn't hit "nuclear stocks" evenly. It hits specific incumbent contracts at specific sites, and Jacobs J and Fluor FLR sit on opposite sides of the ledger depending on which site you're looking at.
Jacobs vs. Fluor: DOE's Cleanup Budget Has Already Picked a Winner at Hanford
A quiet DOE budget reshuffle toward finishing legacy nuclear cleanup over building new reactors favors whichever contractor already holds the badge at the site — and that's increasingly Fluor, not Jacobs.

This isn't a bet on nuclear power growth — it's a bet on which contractor's logo is already on the badge at the site getting the budget.
Who cashes in:
FLR is the biggest structural winner. Fluor co-leads Hanford Tank Waste Operations & Closure (H2C), the joint venture that survived a bid protest to keep the $45 billion, 10-year Hanford Integrated Tank Disposition Contract — the single largest EM contract in the portfolio, covering the underground tank farms holding roughly 56 million gallons of radioactive waste. Fluor also leads Savannah River Nuclear Solutions, whose management-and-operations contract was extended through 2027 (Fluor's share worth roughly $4.5 billion), and is a partner in Savannah River Mission Completion, a JV holding up to $21 billion in ordering authority. That's incumbency on both of DOE's two flagship cleanup sites simultaneously — exactly where a budget that protects "near-term cleanup priorities" over new construction concentrates dollars.
J still cashes in, just from a narrower and less headline-grabbing base. Jacobs leads EM joint ventures at Idaho National Laboratory, the Paducah site in Kentucky, and the West Valley Demonstration Project in New York — real, durable site-services and remediation work that renews on multi-year cycles regardless of who's building new reactors.
BWXT and Amentum, Fluor's H2C partners, capture the same tank-waste tailwind, though neither trades as a pure infrastructure-materials comp here.
Who is exposed:
J is the relative loser on the two contracts that matter most to headline EM dollars. A Jacobs-led team (with Atkins and Westinghouse) protested the Hanford tank-waste award and lost — the court-ordered do-over ultimately reaffirmed H2C, not Jacobs. Jacobs was also not part of the newer Hanford Mission Essential Services Contract, which went to a Leidos-led team. Generic "nuclear renaissance" coverage lumps J and FLR together as engineering beneficiaries of any DOE nuclear spending; site-level incumbency says Fluor now holds the deeper claim on Hanford specifically, DOE's largest single cleanup line item.
The play: This isn't a bet on nuclear power growth — it's a bet on which contractor's logo is already on the badge at the site getting the budget. Watch FY2027 appropriations markups for whether Hanford's proposed 12% funding cut ($3.35B to $2.95B) survives Congress, and watch for any further bid-protest activity around H2C — Fluor's biggest EM exposure rides on that contract staying intact.
Sources: Fluor and DOE press materials; ENR and ExchangeMonitor court-ruling coverage; DOE FY2027 Budget in Brief.
Source: original report ↗
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/moJoin the owners who run ahead of the industry. Cancel anytime, one click.